Evidence map›Paper›PMID 42741428›Full record

ArticleFrontiers in immunology2026

Case Report: Single-cell transcriptomic profiling of a pediatric ALK-negative gastric inflammatory myofibroblastic tumor.

Jusen Nong, Weikun Li, Bo Shi

Abstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jusen NongDepartment of Pediatric Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China.
Weikun LiDepartment of Pediatric Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China.
Bo ShiDepartment of Pediatric Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal neoplasm, approximately 50% of which harbor ALK rearrangements. ALK-negative gastric IMT (G-IMT) in pediatric patients is exceptionally rare and poorly characterized. We report a 6-year-old male with fever, melena, and severe anemia (Hb 30 g/L). Imaging revealed a gastric fundus mass, and subtotal gastrectomy confirmed IMT with dense plasma-cell infiltrate and negative ALK immunostaining. We performed single-cell RNA sequencing on tumor and paired adjacent non-tumor tissue (14,103 cells). CellChat analysis inferred prominent CXCL12-CXCR4 communication between neoplastic myofibroblasts and immune cells. Macrophage subclustering identified an S100A9-high inflammatory tumor-associated macrophage state, and pseudotime analysis placed this state along a continuous transcriptional ordering with resident-like macrophages. To our knowledge, this is the first single-cell transcriptomic characterization of pediatric ALK-negative G-IMT and provides hypothesis-generating insight into its inflammatory microenvironment.

Indexed as

MyofibroblastsNeoplasms, Muscle TissueStomach NeoplasmsTranscriptomeAnaplastic Lymphoma KinaseChildGene Expression ProfilingHumansMaleReceptors, CXCR4Single-Cell AnalysisSingle-Cell Gene Expression AnalysisALK protein, humanAnaplastic Lymphoma KinaseReceptors, CXCR4ALK-negativecase reportinflammatory myofibroblastic tumorpediatricsingle-cell RNA sequencing

Identifiers

PMID42741428
PMCPMC13572716

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.